Intravenous Thrombolytic Treatment in the Oldest Old

Background and Purpose. Intravenous thrombolysis using tissue plasminogen activator is safe and probably effective in patients >80 years old. Nevertheless, its safety has not been specifically addressed for the oldest old patients (≥85 years old, OO). We assessed the safety and effectiveness of t...

Full description

Saved in:
Bibliographic Details
Published in:Stroke Research and Treatment 2012-01, Vol.2012 (2012), p.576-582
Main Authors: García-Caldentey, Juan, Alonso de Leciñana, María, Simal, Patricia, Fuentes, Blanca, Reig, Gemma, Díaz-Otero, Fernando, Guillán, Marta, García, Ana, Martínez, Patricia, García-Pastor, Andrés, Egido, José Antonio, Díez-Tejedor, Exuperio, Gil-Núñez, Antonio, Vivancos, José, Masjuan, Jaime
Format: Article
Language:English
Subjects:
Clinical Study
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Purpose. Intravenous thrombolysis using tissue plasminogen activator is safe and probably effective in patients >80 years old. Nevertheless, its safety has not been specifically addressed for the oldest old patients (≥85 years old, OO). We assessed the safety and effectiveness of thrombolysis in this group of age. Methods. A prospective registry of patients treated with intravenous thrombolysis. Patients were divided in two groups (
ISSN:2090-8105
2042-0056
DOI:10.1155/2012/923676